Has it been FIVE YEARS already?! Celebrations are in order: it's the 5th anniversary of our Nasdaq listing! CHEERS to all of our #TeamCastle members for working so diligently every day to improve patient care! #CastleCares #WeLoveOurPeople❤️ #NasdaqListed
Castle Biosciences, Inc.
Biotechnology Research
Friendswood, Texas 11,939 followers
Improving health through innovative tests that guide patient care
About us
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company focused on transforming disease management by keeping people first—the patients who benefit from the information that our advanced diagnostic tests provide, the clinicians who use our tests to guide disease management decisions, our talented and valued employees, and our investors. Our innovative portfolio of commercial and pipeline tests targets unmet clinical need along the patient care continuum. We currently market six proprietary tests designed to answer clinical questions and address treatment plan challenges facing physicians in dermatologic cancers, uveal melanoma, Barrett’s esophagus, and mental health. https://castletestinfo.com Our test for invasive cutaneous melanoma, DecisionDx®-Melanoma, is a proprietary gene expression profile (GEP) test that uses an individual patient’s tumor biology to predict the risk of metastasis or recurrence, as well as the risk of sentinel lymph node positivity, independent of traditional staging factors. http://bit.ly/DDx-Melanoma DecisionDx®-SCC is our GEP test that predicts the risk of metastasis in patients with cutaneous squamous cell carcinoma, who have one or more risk factors. https://bit.ly/DDx-SCC DecisionDx®-UM, the standard of care in uveal melanoma staging, is our GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer. https://bit.ly/DDx-UM Our comprehensive diagnostic offering — myPath® Melanoma and DiffDx®-Melanoma — provides a highly accurate, objective result to aid dermatopathologists and dermatologists in characterizing suspicious pigmented lesions. https://bit.ly/myPathDiffDx TissueCypher® Barrett’s Esophagus is the world’s first precision medicine test designed to predict future development of esophageal cancer in patients with Barrett’s esophagus. https://tissuecypher.com Castle Biosciences is based in Friendswood, TX and has laboratory operations in Phoenix, AZ, and Pittsburgh, PA.
- Website
-
http://www.castlebiosciences.com
External link for Castle Biosciences, Inc.
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Friendswood, Texas
- Type
- Public Company
- Founded
- 2008
- Specialties
- Diagnostic Cancer Testing, Uveal Melanoma, Cutaneous Melanoma, Melanoma, Skin Cancer, Next Gen Sequencing, Cutaneous Squamous Cell Carcinoma, Gene Expression Profile Tests, Barrett's Esophagus, Esophageal Adenocarcinoma, and Dermatologic Cancer
Locations
-
Primary
505 S Friendswood Dr
Suite 401
Friendswood, Texas 77546, US
-
3737 N 7th St
Suite 160
Phoenix, Arizona 85014, US
-
235 William Pitt Way
B1
Pittsburgh, Pennsylvania 15238, US
Employees at Castle Biosciences, Inc.
Updates
-
#FollowTheLeader with Bob Cook Innovation, Collaboration, and Caring. Hear why these are the top 3 words that come to mind for Bob Cook, head of Castle's R&D team, when he thinks about Castle's culture. #CastleCareers #TeamCastle
-
#TeamCastle hit the Windy City this past weekend to support the Melanoma Research Foundation's Miles for Melanoma Chicago 5K run/walk, joining fellow community members, melanoma patients, survivors, caregivers, and supporters, and helping to raise more than $79K toward their goal. Camilla Zuckero, CarolAnn Motley, Linda Alford #CastleCares #MilesForMelanoma
-
Castle Biosciences, Inc. reposted this
We were joined recently by Mitesh Rao, MD of OMNY Health to discuss its partnership with several of the nation’s leading GI practices to enable insights on patient population characteristics, care delivery patterns, and treatment outcomes based on data extracted from de-identified electronic health records (EHRs). Gastro Broadcast is presented by TissueCypher - Barrett's Esophagus by Castle Biosciences, Inc. #IndepedendentGI #Gastroenterology #Endoscopy
-
Castle has joined forces with television personality, wellness coach and founder of ALL IN by Teddi, host of the Two T’s in a Pod podcast and stage II melanoma survivor Teddi Mellencamp Arroyave to raise awareness around the prevention, detection and management of melanoma, the deadliest form of skin cancer. The campaign will focus on empowering patients impacted by the disease. Details: https://hubs.la/Q02HqT4P0 #YourMelanomaIsYoursToKnow
-
Don't get burned! #DYK just 5 sunburns doubles your risk for #melanoma? But you can prevent burns altogether when you #PracticeSafeSun: cover up, seek shade, wear sunscreen & don't forget your eyes—wear sunglasses! #UVSafetyAwarenessMonth☀️ #ShareTheFacts #CastleCares
-
Castle will release Q2 2024 financial results, hosting a conference call and webcast on Monday, August 5th at 4:30 pm ET. For more details and login information, go to https://hubs.la/Q02GypT_0. #Q2 #earnings
-
We are THRILLED to have won a national Top Workplaces Industry Award in Healthcare for the 2nd consecutive year! Castle ranked 4th out of 95 healthcare companies with 500 or more employees. Comprehensive list of winners: https://hubs.la/Q02GjqmB0 #TopWorkplaces Industry awards celebrate organizations that have built people-first workplace cultures within their sector. Press release: https://hubs.la/Q02Gjt6C0 #CastleCulture #WeLoveOurPeople❤️
-
It's a 3-peat! We are so excited to have been named an Arizona Top Workplace by AZ Central for the 3rd year in a row AND to have earned 5 Top Workplace Culture Excellence Awards (multiple years running) for Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership, and Purpose & Values. https://hubs.la/Q02GjgNq0 #CastleCulture #TopWorkplaces #WeLoveOurPeople❤️
-
Did you know? Prolonged exposure to UV radiation is a major risk factor for developing #SkinCancer, including #melanoma, the most dangerous form. Always #PracticeSafeSun: cover up, seek shade, and wear sunscreen, but don't forget to regularly check your skin. Monitor spots and moles: if they have one or more of the ABCDEs, see your dermatologist. #UVSafetyAwarenessMonth #ShareTheFacts #CastleCares